Clinical trials
Phase 1 Leukemia trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 5 |
| 2019 | 5 |
| 2020 | 2 |
| 2021 | 6 |
| 2022 | 8 |
| 2023 | 1 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 22 |
| Recruiting | 8 |
| Completed | 5 |
| Withdrawn | 3 |
| Terminated | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| iCell Gene Therapeutics | 6 |
| Beijing Boren Hospital | 4 |
| Institute of Hematology & Blood Diseases Hospital, China | 4 |
| Beijing Doing Biomedical Co., Ltd. | 3 |
| Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2 |
| Affiliated Hospital of Nantong University | 1 |
| Affiliated Hospital to Academy of Military Medical Sciences | 1 |
| BeiGene | 1 |
| Beijing 302 Hospital | 1 |
| Beijing GoBroad Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia | 41 |
| Lymphoma | 14 |
| Leukemia, Myeloid, Acute | 12 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 8 |
| Hematologic Neoplasms | 5 |
| Recurrence | 5 |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Leukemia, Myeloid | 3 |
| Lymphoma, B-Cell | 3 |
| Myelodysplastic Syndromes | 3 |
Trials
Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.